Region Skane Lasarettet I Ystad
- Address
- lock Available on a paid plan
Cardiovascular Diseases
Research at Region Skane Lasarettet I Ystad focuses on acute circulatory failure, evaluating whether early vasopressor therapy can shorten time to shock control and reduce intensive care needs.
- Early vasopressor initiation in emergency settings
- Fluid‑only resuscitation comparison
- Outcomes for non‑bleeding hypotensive patients
The study aims to improve emergency department protocols and patient survival.
Neoplasms
The surgical department conducts trials on colorectal cancer with specific genetic alterations, testing if long‑term acetylsalicylic acid reduces disease recurrence.
- Adjuvant aspirin therapy
- PIK3CA/PIK3R1/PTEN mutation‑targeted research
- Time to recurrence as a clinical endpoint
Findings could shape preventive strategies for patients carrying PI3K pathway mutations.
Pathological Conditions, Signs and Symptoms
Investigations also address broader clinical presentations such as hypotension and systemic shock, seeking to refine early intervention tactics.
- Hemodynamic monitoring in acute care
- Impact of early drug administration on symptom progression
- Criteria for ICU admission avoidance
Results are intended to guide clinicians in managing critical signs more effectively.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1Karolinska Institutet1active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 188 other sites in Sweden
Therapeutic Area Benchmark — Sweden
Select a therapeutic area to compare against other sites in Sweden.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Sweden
Market Share
Country: Sweden
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Region Skane Lasarettet I Ystad
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Early Noradrenaline Hydrochloride Versus Standard Fluid Therapy in Non-Bleeding Hypotensive Patients: A Multi-Center Randomized Controlled Trial | Odense University Hospital | Phase III | Recruiting | Dec 2023 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Acetylsalicylic Acid | 1 | Unknown | — | — |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.